---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-032499"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2026-10-13T12:00:11+00:00"
generated_at: "2026-10-13T12:05:44.463221+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.68
calibrated_materiality_score: 0.68
confidence: "high"
source: SEC EDGAR
---

# Mesa Laboratories approves restructuring cutting ~40 jobs, targets $9.3M annualized savings

## Summary
- Board approved the Restructuring Program on October 6, 2026; ~40 positions eliminated (~6% of employees), concentrated in Clinical Genomics plus corporate functions.
- Estimated pre-tax charges of $2.6M-$3.4M, including $2.3M-$3.0M employee costs; cash expenditures of $2.9M-$3.7M, mostly within 12 months.
- Savings Plan targets ~$9.3M in annualized cost reductions with ~$4.3M reinvested, for a net ~$5.0M reduction fully reflected by end of FY2028.
- Hamburg, Germany facility will be exited when its lease expires in February 2027; San Diego, California footprint also reduced.
- CEO Siddhartha Kadia said Clinical Genomics will focus on pharmacogenomics and oncology at scale, accepting lower revenue for higher gross margin; Q2 FY2027 results set for November 9, 2026.

## SEC filing metadata
- accession: 0001437749-26-032499
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2026-10-13T12:00:11+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.68
- calibrated_materiality_score: 0.68
- confidence: high
- sec_items: 2.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774926032499/0001437749-26-032499-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774926032499/mlab20261013_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-032499
- JSON: https://secwatch.observer/filing/0001437749-26-032499.json
- Plain text: https://secwatch.observer/filing/0001437749-26-032499.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.